Celcuity Inc. (CELC) vs Denali Therapeutics Inc. (DNLI)

A side-by-side comparison of Celcuity Inc. and Denali Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CELC vs DNLI

growth of $100 · dividends reinvested · last 9y
CELC +312.4% (+17.1%/yr)DNLI -7.2% (-0.8%/yr)CELC compounded faster over this window
0200400600800Start $1002019202120232025$412$93
CELC DNLI

CELC vs DNLI: by the numbers

  • •CELC is the larger company ($3.45B vs $3.05B market cap).
  • •Both run net losses; CELC's is the smaller (0.00% vs -14191.20% net margin).

Metrics side by side

Valuation

MetricCELCDNLI
P/S ratioN/A846.83
P/B ratioN/A3.65

Profitability

MetricCELCDNLI
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%-14191.20%
ROEN/A-61.24%
ROIC-28.15%-50.82%

Growth (annualized)

MetricCELCDNLI
Revenue CAGR (5Y)N/A20.68%
Total return CAGR (5Y)34.40%-16.91%

Frequently asked

How have CELC and DNLI total returns compared?
Over the past 5 years, CELC delivered 34.40% and DNLI delivered -16.91% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.